From Yahoo Finance: 2025-05-12 16:49:00

Jim Cramer recently revisited his 9 failed predictions from 12 months ago, including Celsius Holdings, Inc. (NASDAQ:CELH) against other stocks. On a recent episode of Mad Money, Cramer urged investors to align their stock choices with their financial goals. Cramer emphasized the importance of understanding personal objectives before investing.

Cramer highlighted the need for discipline in stock picking, stressing the importance of knowing oneself before diving into individual companies. He reminded viewers of the growth potential in the U.S. market, but cautioned against hasty decisions. A list of stocks discussed by Cramer on Mad Money episodes in May 2024 was compiled and analyzed for performance.

Celsius Holdings, Inc. (NASDAQ:CELH) was one of the stocks discussed by Cramer, who expressed preference for the company over its competitor, Monster. However, CELH experienced a significant drop of 53.49%, marking one of Cramer’s worst misses. The company develops fitness-focused energy drinks and has shown potential for investment, but there are other AI stocks with greater promise for higher returns.

Despite Cramer’s optimism towards CELH, there are AI stocks that may offer better returns in a shorter time frame. An AI stock that has shown growth since the beginning of 2025 is highlighted as a potentially more promising investment. For investors seeking AI stocks with high potential at a lower valuation, exploring other options beyond CELH may be beneficial. 1. The CDC reports a record number of COVID-19 cases in the US, with over 100,000 new infections in a single day. Hospitals are reaching capacity, and health officials urge the public to follow safety guidelines to curb the spread of the virus.

2. President-elect Joe Biden unveils his COVID-19 task force, consisting of leading scientists and public health experts. The task force will work to develop a comprehensive plan to address the ongoing pandemic and prioritize the health and safety of Americans.

3. Pfizer announces promising results from its COVID-19 vaccine trial, with an efficacy rate of over 90%. The company plans to seek emergency use authorization from the FDA, potentially making the vaccine available to high-risk populations by the end of the year.

4. In economic news, the US unemployment rate falls to 6.9% in October, down from 7.9% in September. The job market continues to show signs of recovery, with the addition of 638,000 jobs last month, though challenges remain for many industries.

Read more: Was Jim Cramer Right About Celsius Holdings (CELH)?